Related Experiment Video
Updated: Jun 8, 2026

08:10
Capture and Release of Viable Circulating Tumor Cells from Blood
Published on: October 28, 2016
Portable filter-based microdevice for detection and characterization of circulating tumor cells
Henry K Lin1, Siyang Zheng, Anthony J Williams
1Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Summary
A new microdevice effectively captures circulating tumor cells (CTCs) from blood, improving cancer detection and characterization. This portable technology shows higher recovery rates than current methods, aiding cancer patient management.
Area of Science:
- Biomedical Engineering
- Oncology
- Microfluidics
Background:
- Sensitive detection of circulating tumor cells (CTCs) is crucial for revolutionizing cancer patient management.
- Current CTC detection methods face limitations in capture efficiency and cell characterization.
- A novel portable microdevice is developed for improved CTC isolation and analysis.
Purpose of the Study:
- To develop and evaluate a novel parylene membrane filter-based microdevice for CTC isolation.
- To achieve high recovery rates and enable direct on-chip characterization of captured CTCs.
- To compare the performance of the microdevice with the established CellSearch platform.
Main Methods:
- Evaluation of CTC capture sensitivity and efficiency using spiked blood samples from healthy donors.
- Testing 59 model system samples to determine microdevice recovery rates.
- Direct comparison of the microdevice and CellSearch platform using 10 model system samples and 57 patient blood samples.
Main Results:
- The microdevice demonstrated >90% CTC recovery rate in model systems.
- CTCs were detected in 51 of 57 cancer patients using the microdevice, significantly higher than the 26 detected by CellSearch.
- The microdevice consistently recovered greater numbers of CTCs compared to CellSearch when both methods detected cells.
Conclusions:
- The developed filter-based microdevice serves as an effective capture and analysis platform for CTCs.
- The device supports multiplexed imaging and genetic analysis for comprehensive CTC characterization.
- This technology holds potential for routine clinical CTC analysis, improving cancer patient management.

